Premium Brand STROMUSC Winstrol 20mg For Bodybuilding CAS:10418-03-8
Stanozolol occupies a peculiar place in the annals of performance enhancement. Unlike testosterone or nandrolone, it is not a steroid that Nature designed; it is a wholly synthetic pyrazol derivative of dihydrotestosterone, a molecule engineered in the laboratories of Winthrop Laboratories in the late 1950s and released under the trade name Winstrol. The 20 mg tablet—a dosage strength that never existed in the legitimate pharmaceutical pipeline, where the approved oral product was a 2 mg tablet now discontinued in the United States—is a creature of the underground market. Understanding what this preparation actually is, what it does, and what it costs the user requires separating the pharmacological facts from the folklore that surrounds it.
What It Is: The Molecular Identity
Stanozolol is classified formally as a synthetic anabolic-androgenic steroid, specifically a 17α-methylated derivative of 5α-androstan-3-one with a pyrazole ring fused to the A-ring. This structural modification is the key to its behavior. The 17α-methyl group allows the molecule to survive first-pass hepatic metabolism when swallowed, which is why oral administration is feasible at all. The pyrazole ring, meanwhile, is responsible for stanozolol's resistance to the enzyme 3α-hydroxysteroid dehydrogenase, granting it a stability in muscle tissue that many other steroids lack.
The 20 mg tablet is therefore not a pharmaceutical artifact but a compounding or underground laboratory product. Legitimate stanozolol exists as an injectable suspension and, historically, as a 2 mg oral tablet. The 20 mg oral dose represents a bodybuilding-specific concentration, designed for convenience rather than clinical precision. It is worth stating plainly that the United States Food and Drug Administration has never approved stanozolol for the enhancement of athletic performance, and the agency's own labeling for the drug explicitly warns that it has not been shown to be safe or effective for this purpose.


Features: What Distinguishes Stanozolol from Other Steroids
The most consequential feature of stanozolol is its dissociation from estrogenic activity. Unlike testosterone, which aromatizes to estradiol, or nandrolone, which possesses intrinsic progestogenic activity, stanozolol cannot convert to estrogen. This single fact explains much of its appeal and much of its danger. The absence of aromatization means no gynecomastia, no water retention, and no estrogen-driven fat deposition. The physique that emerges from a stanozolol cycle is not puffy or softened; it is dry, hard, and visibly stripped of subcutaneous fluid.
A second feature is its interaction with sex hormone-binding globulin. Stanozolol has a pronounced affinity for SHBG, and its administration produces a measurable suppression of serum SHBG concentrations. By displacing bound testosterone into the free, biologically active fraction, it amplifies the androgenic signal beyond what the steroid's own receptor binding would produce. This is partly why stanozolol is often described as providing a "hardening" effect out of proportion to its relatively modest anabolic rating on paper.
The third feature is its resistance to hepatic breakdown combined with its oral bioavailability. The 17α-methylation that permits oral dosing also renders the molecule hepatotoxic. This is not a theoretical concern. Stanozolol is among the more reliably liver-stressing oral steroids, and the 20 mg dose represents a substantial hepatic burden that is not mitigated by the drug's other properties.
Applications in Bodybuilding: Where It Fits
Stanozolol is not a mass-building drug. It does not produce the dramatic scale weight increases associated with Dianabol or Anadrol, nor does it generate the slow, steady tissue accrual of Deca-Durabolin. Its applications are narrower and more specific.
The first application is contest preparation. In the final weeks before a bodybuilding competition, when the goal shifts from accumulation to definition, stanozolol is deployed to preserve muscle mass during caloric restriction while eliminating the last vestiges of subcutaneous water. A 2023 observational study of Brazilian competitive bodybuilders found stanozolol used at 20 mg three times daily in the week before competition, alongside oxandrolone and other agents. This is a context of extreme pharmacological aggression, not a template for general use.
The second application is strength preservation during a deficit. Stanozolol's androgenic potency supports neural drive and power output even when glycogen stores are depleted and training volume is reduced. Powerlifters and athletes in weight-class sports have historically favored it for this reason, though the drug's detection window and legal status make it a poor choice for anyone subject to testing.
The third application is aesthetic, specifically the pursuit of what is colloquially called the "dry look." Stanozolol does not build large amounts of new tissue, but it changes the appearance of existing tissue by reducing extracellular water and enhancing muscle separation. This effect is transient and entirely dependent on continued administration; it is not a permanent alteration of body composition.
Benefits: What the Evidence Supports
The benefits of stanozolol in a bodybuilding context are real but narrow. The drug reliably increases nitrogen retention and protein synthesis through androgen receptor activation, the fundamental mechanism shared by all anabolic steroids. It suppresses SHBG, raising free testosterone and amplifying the androgenic environment. It does not aromatize, so the user avoids estrogenic side effects entirely. It produces a visible reduction in subcutaneous water, which enhances muscular definition without any actual loss of fat. And it is orally active, which many users find preferable to frequent intramuscular injections.
These benefits must be weighed against a side effect profile that is unusually harsh for a drug of such modest anabolic potency. Stanozolol is notoriously rough on lipids, driving HDL cholesterol downward and shifting the cardiovascular risk profile in a direction that is difficult to justify for cosmetic purposes. It is hepatotoxic, and the 20 mg dose intensifies this. It is androgenic enough to accelerate hair loss in genetically predisposed individuals and to produce acne on the back and shoulders. Women who use it risk virilization-clitoral enlargement, voice deepening, and facial hair growth-at doses far below the 20 mg tablet. And because it is a 17α-methylated compound, it cannot be used indefinitely without inviting hepatic injury.
Dosage and Cycle: The Underground Protocol
There is no medically sanctioned dosage for stanozolol in bodybuilding. The clinical dose for hereditary angioedema, the drug's one remaining legitimate indication in some jurisdictions, is typically 2 mg taken two to three times daily-a fraction of what bodybuilders use. The 20 mg tablet therefore represents a tenfold concentration of the clinical dose in a single pill.
Underground protocols for the 20 mg tablet typically involve 20 to 40 mg per day for men, taken in divided doses to maintain relatively stable blood levels. Some users report taking the entire 20 mg tablet once daily, while others split it into two 10 mg administrations. The cycle length is generally limited by hepatic tolerance: four to six weeks is the common ceiling, and many experienced users will not exceed four weeks at 40 mg daily. Women, if they use oral stanozolol at all, typically employ doses of 2.5 to 5 mg daily for very short periods, though the 20 mg tablet makes accurate dosing for women impractical without splitting the tablet into quarters or eighths.
The injectable form of stanozolol, which avoids the first-pass hepatic exposure but carries its own risks from frequent intramuscular injection of a water-based suspension, is sometimes used at 50 mg every other day. The 20 mg oral tablet is not interchangeable with the injectable on a milligram-for-milligram basis because the pharmacokinetics differ substantially.
Half-Life: A Critical Distinction
The half-life of stanozolol is frequently misrepresented in bodybuilding literature. The oral tablet's half-life is often cited as approximately nine hours, which is a reasonable approximation for the time course of its biological effects, but the actual pharmacokinetic data are more complex. Stanozolol is extensively metabolized, with urinary metabolites including hydroxylated derivatives at the pyrazole ring and various positions on the steroid nucleus. The parent compound is detectable in urine only in small quantities; most of what appears in testing is metabolite.
For detection purposes, the critical figure is not the plasma half-life but the metabolite detection window. Stanozolol metabolites are lipophilic and persist in the body far longer than the active drug itself. Athletes have tested positive for stanozolol metabolites months after their last administration, a fact that has ended careers. The plasma elimination half-life of stanozolol in horses following intra-articular administration has been reported at four to twelve hours, with the drug undetectable in plasma after thirty-six hours. This veterinary data cannot be directly extrapolated to human oral use, but it illustrates the principle: the active molecule clears quickly, while the metabolic footprint lingers.
PCT: Post-Cycle Therapy After Stanozolol
Stanozolol suppresses the hypothalamic-pituitary-testicular axis, though perhaps less profoundly than testosterone or trenbolone at comparable anabolic doses. The suppression is dose-dependent and duration-dependent. A four-week cycle at 20 to 40 mg daily will produce measurable suppression of luteinizing hormone and follicle-stimulating hormone, with a corresponding decline in endogenous testosterone production. The absence of aromatization means there is no estrogen rebound to manage, which simplifies recovery somewhat, but it does not eliminate the need for a structured post-cycle therapy.
A typical PCT after a stanozolol-only cycle begins after the drug's metabolites have sufficiently cleared, usually three to seven days after the last oral dose. The protocol generally involves a selective estrogen receptor modulator such as tamoxifen or clomiphene, administered for three to four weeks at standard doses. Tamoxifen at 20 mg daily or clomiphene at 50 mg daily for the first two weeks, followed by a tapering dose for the remainder, is the conventional approach. Human chorionic gonadotropin is sometimes used in the first week or two of PCT if the cycle was prolonged or if testicular atrophy is pronounced, but it is less critical after a short stanozolol-only cycle than after a long cycle involving aromatizable compounds.
The more important PCT consideration with stanozolol is not hormonal but hepatic. The liver has been under sustained stress from a 17α-methylated compound, and recovery requires abstinence from all hepatotoxic agents, including alcohol and other oral steroids. Some users employ liver support compounds such as N-acetylcysteine or ursodeoxycholic acid during and after the cycle, though the evidence for their efficacy in this specific context is limited. Blood work-a full hepatic panel and a lipid profile-is not optional after a stanozolol cycle; it is the only way to know whether the drug has caused damage that requires medical attention.
Clinical Data
|
Brand |
STROMUSC |
|
Trade names |
Stanozolol, Stromba, Androstanazol; Androstanazole; Stanazol |
|
CAS |
10418-03-8 |
|
Molar mass |
328.500 |
|
Formula |
C21H32N2O |
|
Purity |
Above 98% |
|
Apprarance |
20mg*100 |
Any needs, please contact us
Email: Jasonraws106@gmail.com
WhatsApp: +86-15572565525
Telegram: +86-15871669785

A Final Consideration
The 20 mg Winstrol tablet is a product of the underground market, not of pharmaceutical science. Its existence reflects demand, not evidence. The legitimate medical use of stanozolol has dwindled to a narrow indication in hereditary angioedema, and even there the drug's adverse effect profile has prompted the development of safer alternatives. For bodybuilders, the calculus is straightforward: stanozolol delivers a specific aesthetic result-dryness, hardness, definition-at the cost of hepatic stress, lipid disruption, and androgenic side effects that are particularly unforgiving in women. The 20 mg dose amplifies both the result and the cost. Anyone considering it should understand that the drug is a tool of precision, not of mass, and that its margin for error is narrower than most.
Hot Tags: premium brand stromusc winstrol 20mg for bodybuilding cas:10418-03-8, China premium brand stromusc winstrol 20mg for bodybuilding cas:10418-03-8 manufacturers, suppliers, factory

